Milberg LLP announces that a class action lawsuit was filed in the United States District Court for the Western District of Louisiana on behalf of purchasers of LHC Group, Inc. (NASDAQ:LHCG) common stock between July 30, 2008 and October 26, 2011, (the “Class Period”).
Milberg LLP has created a website ( http://www.LHCGroupLawsuit.com) that seeks to answer questions about shareholder class actions.
The complaint alleges that LHCG maximized revenue by manipulating the number of patient visits, regardless of patient need, and in effect over-billing Medicare.
On October 3, 2011, the Senate Finance Committee concluded that LHCG engaged in a practice that "at best represent[s] abuses of the Medicare home program" and "[a]t worst, they may be examples of for-profit companies defrauding the Medicare home health program at the expense of taxpayers." On October 26, 2011, LHCG lowered its earnings forecast, in part to settle a government inquiry into whether LHCG improperly billed for home health services. LHCG 's stock price fell 15% in reaction to the news.If you purchased LHCG shares during the Class Period you may, no later than August 13, 2012, request that the Court appoint you lead plaintiff of the proposed class. A lead plaintiff is a class member that represents other class members in directing the litigation. Your share in any recovery will not be affected by serving as a lead plaintiff, however, lead plaintiffs make important decisions that could affect the overall recovery for class members. You do not need to be a lead plaintiff to recover. You may retain Milberg LLP, or other attorneys, for this action, but do not need to retain counsel to recover. If this action is certified as a class action, class members will be automatically represented by Court-appointed counsel. The complaint in this action was not filed by Milberg.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV